Jamialahmadi Tannaz, Abbasifard Mitra, Reiner Željko, Kesharwani Prashant, Sahebkar Amirhossein
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
J Clin Med. 2022 Nov 28;11(23):7021. doi: 10.3390/jcm11237021.
: MCP-1 (monocyte chemoattractant protein) plays an important role in early phases of atherogenesis as well as in plaque destabilization, which causes cardiovascular events to play an important role in low-grade inflammation. Obesity, particularly extreme obesity, is a pivotal risk factor for atherosclerosis and many other diseases. In the early stages, bariatric surgery might stop or slow atherogenesis by suppressing inflammation, but also in later stages, preventing plaque destabilization. The aim of this meta-analysis was to provide an answer as to whether bariatric surgery has a significant effect on circulating MCP-1 level or not. : A systematic literature search in PubMed, Scopus, Embase, and Web of Science was performed from inception to 1 January 2022. Meta-analysis was performed using Comprehensive Meta-Analysis (CMA) V2 software. In order to heterogeneity compensation of studies in terms of study design and treatment duration, the characteristics of the studied populations random-effects model and the generic inverse variance weighting method were used. To investigate the relationship with the estimated effect size, a random-effect meta-regression model was used. To assess the exitance of publication bias in the meta-analysis, the funnel plot, Begg's rank correlation, and Egger's weighted regression tests were used. : Meta-analysis of 25 studies with 927 subjects included demonstrated a significant decrease of MCP-1 concentration after bariatric surgery. The data of meta-regression did not indicate any association between the alterations in body mass index (BMI) and absolute difference in MCP-1 levels, but a linear relationship between the changes in MCP-1 and length of follow-up was proven. : Bariatric surgery significantly decreases MCP-1 concentration, but there was no association between the changes in BMI and absolute difference in MCP-1 levels before and after the surgery.
单核细胞趋化蛋白-1(MCP-1)在动脉粥样硬化形成的早期阶段以及斑块不稳定过程中发挥着重要作用,而斑块不稳定会引发心血管事件,在低度炎症中起重要作用。肥胖,尤其是极度肥胖,是动脉粥样硬化和许多其他疾病的关键危险因素。在早期,减肥手术可能通过抑制炎症来阻止或减缓动脉粥样硬化的发生,而且在后期还能防止斑块不稳定。本荟萃分析的目的是回答减肥手术对循环MCP-1水平是否有显著影响。
从数据库建立至2022年1月1日,在PubMed、Scopus、Embase和Web of Science中进行了系统的文献检索。使用综合荟萃分析(CMA)V2软件进行荟萃分析。为了在研究设计和治疗持续时间方面对研究进行异质性补偿,采用了研究人群的随机效应模型和通用逆方差加权方法。为了研究与估计效应量的关系,使用了随机效应荟萃回归模型。为了评估荟萃分析中发表偏倚的存在情况,使用了漏斗图、Begg秩相关检验和Egger加权回归检验。
对纳入的25项研究共927名受试者进行的荟萃分析表明,减肥手术后MCP-1浓度显著降低。荟萃回归数据未表明体重指数(BMI)的变化与MCP-1水平的绝对差异之间存在任何关联,但证实了MCP-1的变化与随访时间长度之间存在线性关系。
减肥手术显著降低MCP-1浓度,但BMI的变化与手术前后MCP-1水平的绝对差异之间没有关联。